This review paper focuses on the genetic contribution, in particular, the association of Apolipoprotein E gene polymorphism to lipid abnormality and subsequent acute coronary syndrome in Han Chinese of China. Many researches have been published pertaining the influence of ApoE gene polymorphism on coronary artery disease, dyslipidemia and the response of statin in Han Chinese. Most of the studies in Han Chinese like other populations demonstrated that ApoE 4 allele genetically predisposes coronary artery disease, acute coronary syndrome, severity of occlusion of coronary artery and higher incidence of major adverse cardiovascular events (In Han Chinese, ApoE allele carriers demonstrated 85% increase in major adverse cardiovascular events (MACE) in six months follow up). In addition, ApoE4 allele carrier also showed both increased in LDL level and decrease response to statin therapy in dyslipidemic Han Chinese. On the other hand, ApoE2 carrier is scavenger of cholesterol and triglyceride from the blood;？thus it is cardiovascular-protective. Despite positive relationship between ApoE gene polymorphism and cardiovascular pathologies, prognostic outcome and resistance to intervention, this area of research still requires？extensive investigation in Han Chinese. Because, several other studies revealed either negative effect or showed no effect by ApoE gene polymorphism on cardiovascular disease. Some of the causes of such debatable results could be explained by factors such as diminutive frequency allele and expression of ApoE gene in coronary heart disease. This part of the research yet requires extensive study with bulkier sample size and retrospective in nature, in order to ascertain the influence of ApoE genotype on lipid, anti-hyperlipidemic agent and coronary heart disease. Such studies could assist us to confirm whether to test healthier subjects to predict genetic risk of coronary heart disease in Han Chinese population. The aim of this review paper is to critically analyze the effect of ApoE gene on the occurrence of coronary heart disease in Han Chinese.
References
[1]
Zhang, X., Lu, Z. and Liu, L. (2008) Coronary Heart Disease in China. Heart, 94, 1126-1131. https://doi.org/10.1136/hrt.2007.132423
[2]
Hu, S. and Kong, L. (2006) Report on Cardiovascular Diseases in China. Encyclopedia of China Publishing House, Beijing, 85.
[3]
Chen, W.W., Gao, R.L., Liu, L.S., Zhu, M.L., Wang, W., Wang, Y.J., et al. (2017) China Cardiovascular Diseases Report 2015: A Summary. Journal of Geriatric Cardiology, 14, 1-10.
[4]
Institute of Medicine Committee on Preventing the Global Epidemic of Cardiovascular Disease (2010) Meeting the Challenges in Developing C. The National Academies Collection: Reports funded by National Institutes of Health. In: Fuster, V. and Kelly, B.B., Eds., Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health, National Academies Press (US) National Academy of Sciences, Washington DC.
[5]
Sahin, S., Ceyhan, K., Benli, I., Ozyurt, H., Naseri, E., Tumuklu, M.M., et al. (2015) Traditional Risk Factors and Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Coronary Artery Disease. Genetics and Molecular Research, 14, 2063-2068. https://doi.org/10.4238/2015.March.20.16
[6]
Wilson, P.W. (1994) Established Risk Factors and Coronary Artery Disease: The Framingham Study. American Journal of Hypertension, 7, 7S-12S.
https://doi.org/10.1093/ajh/7.7.7S
[7]
Wilson, P.W. (2008) Progressing from Risk Factors to Omics. Circulation: Cardiovascular Genetics, 1, 141-146.
https://doi.org/10.1161/CIRCGENETICS.108.815605
[8]
Damani, S.B. and Topol, E.J. (2007) Future Use of Genomics in Coronary Artery Disease. Journal of the American College of Cardiology, 50, 1933-1940.
https://doi.org/10.1016/j.jacc.2007.07.062
[9]
Pang, J., Poulter, E.B., Bell, D.A., Bates, T.R., Jefferson, V.L., Hillis, G.S., et al. (2015) Frequency of Familial Hypercholesterolemia in Patients with Early-Onset Coronary Artery Disease Admitted to a Coronary Care Unit. Journal of Clinical Lipidology, 9, 703-708. https://doi.org/10.1016/j.jacl.2015.07.005
[10]
Mahley, R.W. (1988) Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology. Science, 240, 622-630.
https://doi.org/10.1126/science.3283935
[11]
Scott, J., Knott, T.J., Shaw, D.J. and Brook, J.D. (1985) Localization of Genes Encoding Apolipoproteins CI, CII, and E to the p13→Cen Region of Human Chromosome 19. Human Genetics, 71, 144-146. https://doi.org/10.1007/BF00283370
[12]
Huebbe, P. and Rimbach, G. (2017) Evolution of Human Apolipoprotein E (APOE) Isoforms: Gene Structure, Protein Function and Interaction with Dietary Factors. Ageing Research Reviews, 37, 146-161. https://doi.org/10.1016/j.arr.2017.06.002
[13]
Xia, J., Hu, S., Yin, C. and Xu, D. (2018) A 6-Month Follow-Up Study of the Relation between Apolipoprotein E Gene Polymorphism and Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome. Cardiology, 140, 187-193. https://doi.org/10.1159/000491597
[14]
Mahley, R.W. and Rall Jr., S.C. (2000) Apolipoprotein E: Far More Than a Lipid Transport Protein. Annual Review of Genomics and Human Genetics, 1, 507-537.
https://doi.org/10.1146/annurev.genom.1.1.507
[15]
Song, Y., Stampfer, M.J. and Liu, S. (2004) Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease. Annals of Internal Medicine, 141, 137-147. https://doi.org/10.7326/0003-4819-141-2-200407200-00013
[16]
Larifla, L., Armand, C., Bangou, J., Blanchet-Deverly, A., Numeric, P., Fonteau, C., et al. (2017) Association of APOE Gene Polymorphism with Lipid Profile and Coronary Artery Disease in Afro-Caribbeans. PLoS ONE, 12, e0181620.
https://doi.org/10.1371/journal.pone.0181620
[17]
Corbo, R.M. and Scacchi, R. (1999) Apolipoprotein E (APOE) Allele Distribution in the World. Is APOE*4 a ‘Thrifty’ Allele? Annals of Human Genetics, 63, 301-310.
https://doi.org/10.1046/j.1469-1809.1999.6340301.x
[18]
Wetterau, J.R., Aggerbeck, L.P., Rall Jr., S.C. and Weisgraber, K.H. (1988) Human Apolipoprotein E3 in Aqueous Solution. I. Evidence for Two Structural Domains. The Journal of Biological Chemistry, 263, 6240-6248.
[19]
Saito, H., Dhanasekaran, P., Nguyen, D., Baldwin, F., Weisgraber, K.H., Wehrli, S., et al. (2003) Characterization of the Heparin Binding Sites in Human Apolipoprotein E. The Journal of Biological Chemistry, 278, 14782-14787.
https://doi.org/10.1074/jbc.M213207200
[20]
Phillips, M.C. (2014) Apolipoprotein E Isoforms and Lipoprotein Metabolism. IUBMB Life, 66, 616-623. https://doi.org/10.1002/iub.1314
[21]
Mahley, R.W. and Ji, Z.-S. (1999) Remnant Lipoprotein Metabolism: Key Pathways Involving Cell-Surface Heparan Sulfate Proteoglycans and Apolipoprotein E. Journal of Lipid Research, 40, 1-16.
[22]
Herz, J., Chen, Y., Masiulis, I. and Zhou, L. (2009) Expanding Functions of Lipoprotein Receptors. Journal of Lipid Research, 50, S287-S92.
https://doi.org/10.1194/jlr.R800077-JLR200
[23]
Khoo, C., Campos, H., Judge, H. and Sacks, F.M. (1999) Effects of Estrogenic Oral Contraceptives on the Lipoprotein B Particle System Defined by Apolipoproteins E and C-III Content. Journal of Lipid Research, 40, 202-212.
[24]
Dallongeville, J., Bauge, E., Lebel, P. and Fruchart, J.C. (1997) Fat Ingestion Is Associated with Increased Levels of ApoC-III- and ApoE-B-Containing Lipoprotein Particles in Humans. European Journal of Clinical Investigation, 27, 1055-1060.
https://doi.org/10.1046/j.1365-2362.1997.2350782.x
[25]
Boehm-Cagan, A., Bar, R., Liraz, O., Bielicki, J.K., Johansson, J.O. and Michaelson, D.M. (2016) ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies. Journal of Alzheimer’s Disease, 54, 1219-1233.
https://doi.org/10.3233/JAD-160467
[26]
Weintraub, M.S., Eisenberg, S. and Breslow, J.L. (1987) Dietary Fat Clearance in Normal Subjects Is Regulated by Genetic Variation in Apolipoprotein E. The Journal of Clinical Investigation, 80, 1571-1577. https://doi.org/10.1172/JCI113243
[27]
Bioletto, S., Fontana, P., Darioli, R. and James, R.W. (1998) Apolipoprotein E Polymorphism and the Distribution Profile of Very Low Density Lipoproteins: An Influence of the E4 Allele on Large (Sf > 60) Particles. Atherosclerosis, 138, 207-215.
https://doi.org/10.1016/S0021-9150(98)00002-1
[28]
Chaefer, E.J., Lamon-Fava, S., Johnson, S., Ordovas, J.M., Schaefer, M.M., Castelli, W.P., et al. (1994) Effects of Gender and Menopausal Status on the Association of Apolipoprotein E Phenotype with Plasma Lipoprotein Levels. Results from the Framingham Offspring Study. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14, 1105-1113. https://doi.org/10.1161/01.ATV.14.7.1105
[29]
Dart, A.M. and Cooper, B. (1999) Independent Effects of Apo E Phenotype and Plasma Triglyceride on Lipoprotein Particle Sizes in the Fasting and Postprandial States. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 2465-2473.
https://doi.org/10.1161/01.ATV.19.10.2465
[30]
Topic, A., Spasojevic Kalimanovska, V., Zeljkovic, A., Vekic, J. and Jelic Ivanovic, Z. (2008) Gender-Related Effect of Apo E Polymorphism on Lipoprotein Particle Sizes in the Middle-Aged Subjects. Clinical Biochemistry, 41, 361-367.
https://doi.org/10.1016/j.clinbiochem.2007.11.013
[31]
Akanji, A.O., Suresh, C.G., Fatania, H.R., Al-Radwan, R. and Zubaid, M. (2007) Associations of Apolipoprotein E Polymorphism with Low-Density Lipoprotein Size and Subfraction Profiles in Arab Patients with Coronary Heart Disease. Metabolism: Clinical and Experimental, 56, 484-490.
https://doi.org/10.1016/j.metabol.2006.11.006
[32]
Bach-Ngohou, K., Giraud, F., Krempf, M. and Bard, J.M. (2001) Influence of Remnant Accumulation Markers on Plasma Concentrations of Two Lipoprotein(a) Subspecies (Containing or Free of ApoE). Metabolism: Clinical and Experimental, 50, 277-282. https://doi.org/10.1053/meta.2001.21031
[33]
Moriarty, P.M., Varvel, S.A., Gordts, P.L., McConnell, J.P. and Tsimikas, S. (2017) Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 580-588. https://doi.org/10.1161/ATVBAHA.116.308704
[34]
Moreno, J.A., Perez-Jimenez, F., Marin, C., Gomez, P., Perez-Martinez, P., Moreno, R., et al. (2004) The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects. The Journal of Nutrition, 134, 2517-2522.
https://doi.org/10.1093/jn/134.10.2517
[35]
Zhang, S.H., Reddick, R.L., Piedrahita, J.A. and Maeda, N. (1992) Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E. Science, 258, 468-471. https://doi.org/10.1126/science.1411543
[36]
Lu, Z., Wu, X., Jin, X., Peng, F. and Lin, J. (2016) Apolipoprotein E ε2/ε3/ε4 Variant in Association with Obstructive Sleep Apnoea and Lipid Profile: A Meta-Analysis. The Journal of International Medical Research, 44, 3-14.
https://doi.org/10.1177/0300060515611539
[37]
Al Harthi, F., Huraib, G.B., Zouman, A., Arfin, M., Tariq, M. and Al-Asmari, A. (2014) Apolipoprotein E Gene Polymorphism and Serum Lipid Profile in Saudi Patients with Psoriasis. Disease Markers, 2014, Article ID: 239645.
https://doi.org/10.1155/2014/239645
[38]
El-Lebedy, D., Raslan, H.M. and Mohammed, A.M. (2016) Apolipoprotein E Gene Polymorphism and Risk of Type 2 Diabetes and Cardiovascular Disease. Cardiovascular Diabetology, 15, 12. https://doi.org/10.1186/s12933-016-0329-1
[39]
Procopciuc, L.M., Caracostea, G., Zaharie, G. and Stamatian, F. (2015) Newborn APOE Genotype Influences Maternal Lipid Profile and the Severity of High-Risk Pregnancy—Preeclampsia: Interaction with Maternal Genotypes as a Modulating Risk Factor in Preeclampsia. Hypertension in Pregnancy, 34, 271-283.
https://doi.org/10.3109/10641955.2015.1009541
[40]
Boulenouar, H., Mediene Benchekor, S., Meroufel, D.N., Lardjam Hetraf, S.A., Ouhaibi Djellouli, H., Hermant, X., et al. (2013) Impact of APOE Gene Polymorphisms on the Lipid Profile in an Algerian Population. Lipids in Health and Disease, 12, 155. https://doi.org/10.1186/1476-511X-12-155
[41]
Versmissen, J., Oosterveer, D.M., Hoekstra, M., Out, R., Berbee, J.F., Blommesteijn-Touw, A.C., et al. (2011) Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations. Circulation Cardiovascular Genetics, 4, 655-660.
https://doi.org/10.1161/CIRCGENETICS.111.959858
[42]
Gan, W., Liu, Y., Luo, K.H., Liang, S.S., Wang, H., Li, M., et al. (2018) The Prevalence Change of Hyperlipidemia and Hyperglycemia and the Effectiveness of Yearly Physical Examinations: An Eight-Year Study in Southwest China. Lipids in Health and Disease, 17, 70. https://doi.org/10.1186/s12944-018-0724-6
[43]
Xiang, R., Fan, L.L., Lin, M.J., Li, J.J., Shi, X.Y., Jin, J.Y., et al. (2017) The Genetic Spectrum of Familial Hypercholesterolemia in the Central South Region of China. Atherosclerosis, 258, 84-88. https://doi.org/10.1016/j.atherosclerosis.2017.02.007
[44]
Xu, X., Li, J., Sheng, W. and Liu, L. (2008) Meta-Analysis of Genetic Studies from Journals Published in China of Ischemic Stroke in the Han Chinese Population. Cerebrovascular Diseases, 26, 48-62. https://doi.org/10.1159/000135653
[45]
Corsetti, J.P., Sparks, C.E., Bakker, S.J.L., Gruppen, E.G. and Dullaart, R.P.F. (2018) Roles of High Apolipoprotein E Blood Levels and HDL in Development of Familial Dysbetalipoproteinemia in ε2ε2 Subjects. Clinical Biochemistry, 52, 67-72.
https://doi.org/10.1016/j.clinbiochem.2017.11.010
[46]
Kitahara, M., Shinomiya, M., Shirai, K., Saito, Y. and Yoshida, S. (1990) Frequency and Role of Apo E Phenotype in Familial Hypercholesterolemia and Non-Familial Hyperlipidemia in the Japanese. Atherosclerosis, 82, 197-204.
https://doi.org/10.1016/0021-9150(90)90041-G
[47]
Xia, Y., Sass, C., Shen, X., Siest, G. and Visvikis, S. (2000) Associations of Apolipoprotein E Concentration and Polymorphism with Lipids and Apolipoprotein Levels in Chinese from Beijing and Shanghai. Clinical Chemistry and Laboratory Medicine, 38, 655-659. https://doi.org/10.1515/CCLM.2000.094
[48]
Kajinami, K., Takekoshi, N., Brousseau, M.E. and Schaefer, E.J. (2004) Pharmacogenetics of HMG-CoA Reductase Inhibitors: Exploring the Potential for Genotype-Based Individualization of Coronary Heart Disease Management. Atherosclerosis, 177, 219-234. https://doi.org/10.1016/j.atherosclerosis.2004.09.004
[49]
Mangravite, L.M., Thorn, C.F. and Krauss, R.M. (2006) Clinical Implications of Pharmacogenomics of Statin Treatment. The Pharmacogenomics Journal, 6, 360-374.
https://doi.org/10.1038/sj.tpj.6500384
[50]
Banach, M., Stulc, T., Dent, R. and Toth, P.P. (2016) Statin Non-Adherence and Residual Cardiovascular Risk: There Is Need for Substantial Improvement. International Journal of Cardiology, 225, 184-196.
https://doi.org/10.1016/j.ijcard.2016.09.075
[51]
Zintzaras, E., Kitsios, G.D., Triposkiadis, F., Lau, J. and Raman, G. (2009) APOE Gene Polymorphisms and Response to Statin Therapy. The Pharmacogenomics Journal, 9, 248-257. https://doi.org/10.1038/tpj.2009.25
[52]
Kirac, D., Bayam, E., Dagdelen, M., Gezmis, H., Sarikaya, S., Pala, S., et al. (2017) HMGCR and ApoE Mutations May Cause Different Responses to Lipid Lowering Statin Therapy. Cellular and Molecular Biology, 63, 43-48.
https://doi.org/10.14715/cmb/2017.63.10.6
[53]
Hu, M., Mak, V.W. and Tomlinson, B. (2012) Polymorphisms in Apolipoprotein E and Apolipoprotein A-V Do Not Influence the Lipid Response to Rosuvastatin but Are Associated with Baseline Lipid Levels in Chinese Patients with Hyperlipidemia. Journal of Clinical Lipidology, 6, 585-592. https://doi.org/10.1016/j.jacl.2012.02.005
[54]
Zhang, Y., Wei, D.D., Yuan, R.R., Ge, Q.X., Chen, F., Yang, S.X., et al. (2017) Effects of ApoE Gene Polymorphism on the Efficacy of Atorvastatin in the Treatment of Hyperlipidemia. National Medical Journal of China, 97, 291-294.
[55]
Tavintharan, S., Lim, S.C., Chan, Y.H. and Sum, C.F. (2007) Apolipoprotein E Genotype Affects the Response to Lipid-Lowering Therapy in Chinese Patients with Type 2 Diabetes Mellitus. Diabetes, Obesity & Metabolism, 9, 81-86.
https://doi.org/10.1111/j.1463-1326.2006.00577.x
[56]
Mahley, R.W., Weisgraber, K.H. and Huang, Y. (2009) Apolipoprotein E: Structure Determines Function, from Atherosclerosis to Alzheimer’s Disease to AIDS. The Journal of Lipid Research, 50, S183-S188.
https://doi.org/10.1194/jlr.R800069-JLR200
[57]
Kritharides, L., Nordestgaard, B.G., Tybjaerg-Hansen, A., Kamstrup, P.R. and Afzal, S. (2017) Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis. The Journal of Clinical Endocrinology and Metabolism, 102, 3390-3399.
https://doi.org/10.1210/jc.2017-01049
[58]
Tyynela, P., Goebeler, S., Ilveskoski, E., Mikkelsson, J., Perola, M., Lehtimaki, T., et al. (2013) Age-Dependent Interaction of Apolipoprotein E Gene with Eastern Birthplace in Finland Affects Severity of Coronary Atherosclerosis and Risk of Fatal Myocardial Infarction—Helsinki Sudden Death Study. Annals of Medicine, 45, 213-219. https://doi.org/10.3109/07853890.2012.727021
[59]
Tanguturi, P., Pullareddy, B., Kumar, P.S. and Murthy, D.K. (2013) Association between Apolipoprotein E Gene Polymorphism and Myocardial Infarction. Biochemical Genetics, 51, 398-405. https://doi.org/10.1007/s10528-013-9572-2
[60]
Xu, H., Li, H., Liu, J., Zhu, D., Wang, Z., Chen, A., et al. (2014) Meta-Analysis of Apolipoprotein E Gene Polymorphism and Susceptibility of Myocardial Infarction. PLoS ONE, 9, e104608. https://doi.org/10.1371/journal.pone.0104608
[61]
Ranjith, N., Pegoraro, R.J., Rom, L., Rajput, M.C. and Naidoo, D.P. (2004) Lp(a) and ApoE Polymorphisms in Young South African Indians with Myocardial Infarction. Cardiovascular Journal of South Africa: Official Journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners, 15, 111-117.
[62]
Zhao, Q.R., Lei, Y.Y., Li, J., Jiang, N. and Shi, J.P. (2017) Association between Apolipoprotein E Polymorphisms and Premature Coronary Artery Disease: A Meta-Analysis. Clinical Chemistry and Laboratory Medicine, 55, 284-298.
https://doi.org/10.1515/cclm-2016-0145
[63]
Xu, S., Yin, X., Li, S., Jin, W., Lou, H., Yang, L., et al. (2009) Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies. The American Journal of Human Genetics, 85, 762-774.
https://doi.org/10.1016/j.ajhg.2009.10.015
[64]
Zhang, M.D., Gu, W., Qiao, S.B., Zhu, E.J., Zhao, Q.M. and Lv, S.Z. (2014) Apolipoprotein E Gene Polymorphism and Risk for Coronary Heart Disease in the Chinese Population: A Meta-Analysis of 61 Studies Including 6634 Cases and 6393 Controls. PLoS ONE, 9, e95463. https://doi.org/10.1371/journal.pone.0095463
[65]
Liang, S., Pan, M., Geng, H.H., Chen, H., Gu, L.Q., Qin, X.T., et al. (2009) Apolipoprotein E Polymorphism in Normal Han Chinese Population: Frequency and Effect on Lipid Parameters. Molecular Biology Reports, 36, 1251-1256.
https://doi.org/10.1007/s11033-008-9305-5
[66]
Yin, Y.W., Sun, Q.Q., Zhang, B.B., Hu, A.M., Liu, H.L., Wang, Q., et al. (2013) Association between Apolipoprotein E Gene Polymorphism and the Risk of Coronary Artery Disease in Chinese Population: Evidence from a Meta-Analysis of 40 Studies. PLoS ONE, 8, e66924. https://doi.org/10.1371/journal.pone.0066924
[67]
Bai, X., Zhao, M. and Wang, B. (2001) Dyslipidemia-Related Risk Factors for Myocardial Infarction and Polymorphism of ApoE Gene among Myocardial Infarction Patients and Their Siblings. National Medical Journal of China, 81, 340-343.
[68]
Baum, L., Ng, H.K., Wong, K.S., Tomlinson, B., Rainer, T.H., Chen, X., et al. (2006) Associations of Apolipoprotein E Exon 4 and Lipoprotein Lipase S447X Polymorphisms with Acute Ischemic Stroke and Myocardial Infarction. Clinical Chemistry and Laboratory Medicine, 44, 274-281. https://doi.org/10.1515/CCLM.2006.047
[69]
Kip, K.E., Hollabaugh, K., Marroquin, O.C. and Williams, D.O. (2008) The Problem with Composite End Points in Cardiovascular Studies: The Story of Major Adverse Cardiac Events and Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 51, 701-707. https://doi.org/10.1016/j.jacc.2007.10.034
[70]
Cenarro, A., Etxebarria, A., de Castro-Oros, I., Stef, M., Bea, A.M., Palacios, L., et al. (2016) The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-Regulation of LDL Receptor Expression in Hepatocytes. The Journal of Clinical Endocrinology and Metabolism, 101, 2113-2121.
https://doi.org/10.1210/jc.2015-3874
[71]
Plump, A.S., Smith, J.D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J.G., et al. (1992) Severe Hypercholesterolemia and Atherosclerosis in Apolipoprotein E-Deficient Mice Created by Homologous Recombination in ES Cells. Cell, 71, 343-353. https://doi.org/10.1016/0092-8674(92)90362-G
